Review




Structured Review

Procell Inc normal hpasmcs
CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated <t>hPASMCs</t> reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).
Normal Hpasmcs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+hpasmcs/human+pasmcs/pmc12584869-73-0-5
Average 86 stars, based on 1 article reviews
normal hpasmcs - by Bioz Stars, 2026-11
86/100 stars

Images

1) Product Images from "Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling"

Article Title: Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling

Journal: Cell Proliferation

doi: 10.1111/cpr.13817

CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated hPASMCs reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).
Figure Legend Snippet: CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated hPASMCs reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).

Techniques Used: Over Expression, Expressing, Flow Cytometry

Related Articles

Cell Culture:

Article Title: TRAF6 mediates vascular remodeling via endoplasmic reticulum stress-mitophagy in hypoxic pulmonary hypertension.
Article Snippet: Background: Hypoxia-induced pulmonary hypertension (HPH) is a cardiopulmonary disease marked by pulmonary vascular remodeling and elevated resistance in the pulmonary arteries.. Tumor necrosis factor receptor-associated factor 6 (TRAF6) is a key mediator in the pathophysiology of multiple diseases, yet its functional involvement in HPH remains poorly understood.. Methods: We first examined TRAF6 expression and localization in lung tissues from HPH patients and experimental mouse models using Western blotting and immunofluorescence.

Article Title: H 2 S Donor Therapy Reverses Established Pulmonary Arterial Hypertension and Pulmonary Vascular Structural Remodeling in Rats
Article Snippet: .. The hPASMCs (Procell, Wuhan, China) were cultured in specialized medium at 37 °C and 5% CO 2 . .. After overnight starvation in serum-free conditions, hPASMCs in the hypoxia group were transferred to a hypoxic incubator (1% O 2 , 5% CO 2 , 37 °C) for 12 h. Subsequently, 100 μM NaHS or 100 μM GYY4137 [ ] (HY-107632, MCE, Shanghai, China) was added, with or without 50 μM dithiothreitol (DTT), and incubation continued for a further 24 h under the same hypoxic conditions.

Article Title: H 2 S Donor Therapy Reverses Established Pulmonary Arterial Hypertension and Pulmonary Vascular Structural Remodeling in Rats.
Article Snippet: .. The hPASMCs (Procell, Wuhan, China) were cultured in specialized medium at 37 ◦C and 5% CO2. .. After overnight starvation in serum-free conditions, hPASMCs in the hypoxia group were transferred to a hypoxic incubator (1% O2, 5% CO2, 37 ◦C) for 12 h. Subsequently, 100 μM NaHS or 100 μM GYY4137 [18] (HY-107632, MCE, Shanghai, https://doi.org/10.3390/biomedicines14040760 China) was added, with or without 50 μM dithiothreitol (DTT), and incubation continued for a further 24 h under the same hypoxic conditions.

Article Title: MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension
Article Snippet: e164 May 2025 Arterioscler Thromb Vasc Biol.. 2025;45:e164–e183.. DOI: 10.1161/ATVBAHA.124.322337 Arterioscler Thromb Vasc Biol is available at www.ahajournals.org/journal/atvb Correspondence to: Panpan Hao, MD, PhD, Department of Cardiology, Qilu Hospital of Shandong University, No. 107 Wenhuaxi Rd, Jinan 250012, Shandong, P.R.

Article Title: Epigenetically activated MIR100HG regulates UPF1-mediated oxidative stress to promote pulmonary vascular immune microenvironment remodeling.
Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article.

In Vitro:

Article Title: Bioinformatics-based identification and experimental validation of biomarkers in pulmonary arterial hypertension.
Article Snippet: .. In Vitro Cell Model Establishment We used primary hPASMCs purchased from Wuhan Procell Life Science & Technology Corporation. ..



Similar Products

99
ATCC human pulmonary artery smooth muscle cells hpasmcs
The negative correlation between miR-661 and CCND2 in pulmonary hypertension patients. ( A ) <t>HPASMCs</t> were overexpressed with miR-661, followed by RNA-seq analysis. The heatmap result showed the differentially expressed genes as indicated. ( B ) qRT-PCR was used to detect the expression level of miR-661 and CCND2 in serum of patients with pulmonary hypertension and healthy volunteers, then the correlation analysis were performed. ( C ) Statistics of KEGG pathway were performed after overexpressed with miR-661 in HPASMCs, the green highlighted text indicates that the cell cycle pathway was significantly inhibited.
Human Pulmonary Artery Smooth Muscle Cells Hpasmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+hpasmcs/Primary+Pulmonary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pmc13225285-69-7-25
Average 99 stars, based on 1 article reviews
human pulmonary artery smooth muscle cells hpasmcs - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC pulmonary artery smooth muscle cells hpasmcs
The negative correlation between miR-661 and CCND2 in pulmonary hypertension patients. ( A ) <t>HPASMCs</t> were overexpressed with miR-661, followed by RNA-seq analysis. The heatmap result showed the differentially expressed genes as indicated. ( B ) qRT-PCR was used to detect the expression level of miR-661 and CCND2 in serum of patients with pulmonary hypertension and healthy volunteers, then the correlation analysis were performed. ( C ) Statistics of KEGG pathway were performed after overexpressed with miR-661 in HPASMCs, the green highlighted text indicates that the cell cycle pathway was significantly inhibited.
Pulmonary Artery Smooth Muscle Cells Hpasmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+hpasmcs/Primary+Pulmonary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm41232621-59-12-23
Average 99 stars, based on 1 article reviews
pulmonary artery smooth muscle cells hpasmcs - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Procell Inc normal hpasmcs
CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated <t>hPASMCs</t> reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).
Normal Hpasmcs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+hpasmcs/human+pasmcs/pmc12584869-73-0-5
Average 86 stars, based on 1 article reviews
normal hpasmcs - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

99
ATCC human pa smooth muscle cells hpasmcs
CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated <t>hPASMCs</t> reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).
Human Pa Smooth Muscle Cells Hpasmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+hpasmcs/Primary+Pulmonary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/10__1161_slash_atvbaha__123__319916-144-0-9
Average 99 stars, based on 1 article reviews
human pa smooth muscle cells hpasmcs - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC primary human pulmonary arterial smooth muscle cells hpasmcs
CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated <t>hPASMCs</t> reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).
Primary Human Pulmonary Arterial Smooth Muscle Cells Hpasmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+hpasmcs/Primary+Pulmonary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm38635022-28-0-12
Average 99 stars, based on 1 article reviews
primary human pulmonary arterial smooth muscle cells hpasmcs - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC human pulmonary arterial smooth muscle cells hpasmcs
CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated <t>hPASMCs</t> reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).
Human Pulmonary Arterial Smooth Muscle Cells Hpasmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+hpasmcs/Primary+Pulmonary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm38194707-77-24-34
Average 99 stars, based on 1 article reviews
human pulmonary arterial smooth muscle cells hpasmcs - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
Lonza normal hpasmc
MiR-212-5p is an “anti-proliferative” miRNA in PASMC (A) Normal human PASMCs (hPASMCs, Lonza) were transfected with miR-212-5p or negative control miR inhibitor (Anti-miR-212 versus Anti-Neg). BrdU incorporation assay was performed. Proliferation level of PASMCs transfected with negative control miR inhibitor (Anti-Neg) was set as 1 and served as controls. Proliferation level of PASMCs transfected with miR-212-5p inhibitor (Anti-miR-212) was compared with that of control <t>cells.</t> <t>Inhibition</t> of miR-212-5p induced PASMC proliferation in vitro in room air. (B) Normal <t>hPASMC</t> (Lonza) were transfected with miR-212-5p or negative control miR mimic and then exposed to room air (N) or hypoxia (H, 1% O 2 ) for 24 h. BrdU incorporation assay was performed to determine the relative proliferation level of these cells. Proliferation level of PASMCs transfected with negative control miR mimic (Neg mimic) and exposed to room air was set as 1 and served as controls. Proliferation levels of PASMCs in other groups were compared with that of control cells. miR-212-5p mimic significantly suppressed PASMC proliferation in both room air and hypoxia. (C) Normal hPASMCs (Lonza) were infected with adenoviral particles that express miR-212-5p (Ad-miR212, 100 PFUs/cell) or control adenoviral particles (Ad-Ctrl, 100 PFUs/cell) on day 1. Then cells were collected for cell counting on day 3 and 5, respectively. Overexpression of miR-212-5p significantly suppressed cell growth in room air. (D) Human PASMCs of PH patient (PH hPASMCs) were transfected with miR-212-5p or negative control miR mimic. BrdU incorporation assay was performed and relative cell proliferation level was compared, as described above. miR-212-5p mimic also significantly suppressed proliferation of PH hPASMCs. Data are presented as mean ± SEM. ∗ or ∗∗ versus room air Anti-Neg, Neg mimic control, or Ad-Ctrl, respectively; ## versus hypoxic Neg mimic control. ∗p < 0.05, ∗∗ or ##p < 0.01.
Normal Hpasmc, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+hpasmcs/hpasmc/pmc09289783-32-12-14
Average 90 stars, based on 1 article reviews
normal hpasmc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


The negative correlation between miR-661 and CCND2 in pulmonary hypertension patients. ( A ) HPASMCs were overexpressed with miR-661, followed by RNA-seq analysis. The heatmap result showed the differentially expressed genes as indicated. ( B ) qRT-PCR was used to detect the expression level of miR-661 and CCND2 in serum of patients with pulmonary hypertension and healthy volunteers, then the correlation analysis were performed. ( C ) Statistics of KEGG pathway were performed after overexpressed with miR-661 in HPASMCs, the green highlighted text indicates that the cell cycle pathway was significantly inhibited.

Journal: Biologics : Targets & Therapy

Article Title: MicroRNA-661 Suppresses Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells and Endothelial Cells by Targeting CCND2

doi: 10.2147/BTT.S592879

Figure Lengend Snippet: The negative correlation between miR-661 and CCND2 in pulmonary hypertension patients. ( A ) HPASMCs were overexpressed with miR-661, followed by RNA-seq analysis. The heatmap result showed the differentially expressed genes as indicated. ( B ) qRT-PCR was used to detect the expression level of miR-661 and CCND2 in serum of patients with pulmonary hypertension and healthy volunteers, then the correlation analysis were performed. ( C ) Statistics of KEGG pathway were performed after overexpressed with miR-661 in HPASMCs, the green highlighted text indicates that the cell cycle pathway was significantly inhibited.

Article Snippet: The human embryonic Kidney 293T cells (HEK293T), human pulmonary artery smooth muscle Cells (HPASMCs) and human pulmonary artery endothelial cells (HPAECs) were obtained from the American Type Culture Collection.

Techniques: RNA Sequencing, Quantitative RT-PCR, Expressing

CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated hPASMCs reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).

Journal: Cell Proliferation

Article Title: Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling

doi: 10.1111/cpr.13817

Figure Lengend Snippet: CITED2 can affect the proliferation of idiopathic PAH patient cells. (A) The overexpression efficiency of the CITED2 was detected in iPAH patient cells. (B) Expression changes of CITED2 in iPAH patient cells. (C) The CCK8 experiment showed that overexpression of CITED2 could affect the growth and viability of cells. (D, E) After overexpression of CITED2, the levels of cell cycle‐related proteins decreased in patients. (F) Overexpression of CITED2 in hypoxia‐treated hPASMCs reduced Ki67 levels in the cells. (G) Flow cytometry results showed that overexpression of CITED2 reduced the proportion of cells in the G2/M phase and S phase and affected cell cycle progression. (H) After overexpression of CITED2, the expression of PCNA in patient cells decreased. (I, J) Overexpression of CITED2 in hypoxia‐treated hPASMCs also affected the expression of cell cycle‐related proteins. (Bar = mean ± S.E.M, * p < 0.05; ** p < 0.01).

Article Snippet: Normal hPASMCs were purchased from Procell Life Science & Technology Co. Ltd.

Techniques: Over Expression, Expressing, Flow Cytometry

MiR-212-5p is an “anti-proliferative” miRNA in PASMC (A) Normal human PASMCs (hPASMCs, Lonza) were transfected with miR-212-5p or negative control miR inhibitor (Anti-miR-212 versus Anti-Neg). BrdU incorporation assay was performed. Proliferation level of PASMCs transfected with negative control miR inhibitor (Anti-Neg) was set as 1 and served as controls. Proliferation level of PASMCs transfected with miR-212-5p inhibitor (Anti-miR-212) was compared with that of control cells. Inhibition of miR-212-5p induced PASMC proliferation in vitro in room air. (B) Normal hPASMC (Lonza) were transfected with miR-212-5p or negative control miR mimic and then exposed to room air (N) or hypoxia (H, 1% O 2 ) for 24 h. BrdU incorporation assay was performed to determine the relative proliferation level of these cells. Proliferation level of PASMCs transfected with negative control miR mimic (Neg mimic) and exposed to room air was set as 1 and served as controls. Proliferation levels of PASMCs in other groups were compared with that of control cells. miR-212-5p mimic significantly suppressed PASMC proliferation in both room air and hypoxia. (C) Normal hPASMCs (Lonza) were infected with adenoviral particles that express miR-212-5p (Ad-miR212, 100 PFUs/cell) or control adenoviral particles (Ad-Ctrl, 100 PFUs/cell) on day 1. Then cells were collected for cell counting on day 3 and 5, respectively. Overexpression of miR-212-5p significantly suppressed cell growth in room air. (D) Human PASMCs of PH patient (PH hPASMCs) were transfected with miR-212-5p or negative control miR mimic. BrdU incorporation assay was performed and relative cell proliferation level was compared, as described above. miR-212-5p mimic also significantly suppressed proliferation of PH hPASMCs. Data are presented as mean ± SEM. ∗ or ∗∗ versus room air Anti-Neg, Neg mimic control, or Ad-Ctrl, respectively; ## versus hypoxic Neg mimic control. ∗p < 0.05, ∗∗ or ##p < 0.01.

Journal: Molecular Therapy. Nucleic Acids

Article Title: MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents

doi: 10.1016/j.omtn.2022.06.008

Figure Lengend Snippet: MiR-212-5p is an “anti-proliferative” miRNA in PASMC (A) Normal human PASMCs (hPASMCs, Lonza) were transfected with miR-212-5p or negative control miR inhibitor (Anti-miR-212 versus Anti-Neg). BrdU incorporation assay was performed. Proliferation level of PASMCs transfected with negative control miR inhibitor (Anti-Neg) was set as 1 and served as controls. Proliferation level of PASMCs transfected with miR-212-5p inhibitor (Anti-miR-212) was compared with that of control cells. Inhibition of miR-212-5p induced PASMC proliferation in vitro in room air. (B) Normal hPASMC (Lonza) were transfected with miR-212-5p or negative control miR mimic and then exposed to room air (N) or hypoxia (H, 1% O 2 ) for 24 h. BrdU incorporation assay was performed to determine the relative proliferation level of these cells. Proliferation level of PASMCs transfected with negative control miR mimic (Neg mimic) and exposed to room air was set as 1 and served as controls. Proliferation levels of PASMCs in other groups were compared with that of control cells. miR-212-5p mimic significantly suppressed PASMC proliferation in both room air and hypoxia. (C) Normal hPASMCs (Lonza) were infected with adenoviral particles that express miR-212-5p (Ad-miR212, 100 PFUs/cell) or control adenoviral particles (Ad-Ctrl, 100 PFUs/cell) on day 1. Then cells were collected for cell counting on day 3 and 5, respectively. Overexpression of miR-212-5p significantly suppressed cell growth in room air. (D) Human PASMCs of PH patient (PH hPASMCs) were transfected with miR-212-5p or negative control miR mimic. BrdU incorporation assay was performed and relative cell proliferation level was compared, as described above. miR-212-5p mimic also significantly suppressed proliferation of PH hPASMCs. Data are presented as mean ± SEM. ∗ or ∗∗ versus room air Anti-Neg, Neg mimic control, or Ad-Ctrl, respectively; ## versus hypoxic Neg mimic control. ∗p < 0.05, ∗∗ or ##p < 0.01.

Article Snippet: Inhibition of miR-212-5p induced PASMC proliferation in vitro in room air. (B) Normal hPASMC (Lonza) were transfected with miR-212-5p or negative control miR mimic and then exposed to room air (N) or hypoxia (H, 1% O 2 ) for 24 h. BrdU incorporation assay was performed to determine the relative proliferation level of these cells.

Techniques: Transfection, Negative Control, BrdU Incorporation Assay, Control, Inhibition, In Vitro, Infection, Cell Counting, Over Expression